Softech Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-01-2025
- Paid Up Capital ₹ 5.63 M
as on 11-01-2025
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.75 Cr
as on 11-01-2025
- Satisfied Charges ₹ 16.90 Cr
as on 11-01-2025
- Revenue -9.73%
(FY 2024)
- Profit -11.59%
(FY 2024)
- Ebitda -22.40%
(FY 2024)
- Net Worth -10.15%
(FY 2024)
- Total Assets -15.79%
(FY 2024)
About Softech Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.63 M.
The company currently has active open charges totaling ₹4.75 Cr. The company has closed loans amounting to ₹16.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mitul Thakker, Asha Thakker, and Nitin Thakker serve as directors at the Company.
- CIN/LLPIN
U24231MH2003PTC271167
- Company No.
271167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2003
- Date of AGM
09 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Softech Pharma Private Limited offer?
Softech Pharma Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service, Business Planning and Management, Business Consultant, Medical Treatment Services.
Who are the key members and board of directors at Softech Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mitul Thakker  | Director | 06-Jan-2005 | Current |
| Asha Thakker | Director | 09-Dec-2022 | Current |
| Nitin Thakker | Director | 10-Oct-2003 | Current |
Financial Performance of Softech Pharma.
Softech Pharma Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 9.73% decrease. The company also saw a substantial fall in profitability, with a 11.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Softech Pharma?
In 2023, Softech Pharma had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Soft Healthcare Private LimitedActive 10 years 6 monthsMitul Thakker and Nitin Thakker are mutual person
E-Square Leisure Private LimitedActive 39 years 1 monthMitul Thakker and Nitin Thakker are mutual person
- Mitul Enterprises Private LimitedActive 27 years 25 days
Mitul Thakker, Asha Thakker and 1 more are mutual person
Charges (Loans)
₹4.75 Cr
₹16.90 Cr
Charges Breakdown by Lending Institutions
- Uti Bank Limited : 2.75 Cr
- Axis Bank Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2021 | Axis Bank Limited | ₹2.00 Cr | Open |
| 19 Jan 2006 | Uti Bank Limited | ₹2.75 Cr | Open |
| 23 Mar 2021 | Axis Bank Limited | ₹14.75 Cr | Satisfied |
| 15 Sep 2004 | U.T.I. Bank Limited | ₹2.15 Cr | Satisfied |
How Many Employees Work at Softech Pharma?
Unlock and access historical data on people associated with Softech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Softech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Softech Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
